{"transactions":[{"id":844624,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-13T21:28:46.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":3162,"price":71.64,"value":226525.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $70.27 to $72.62. The price reported above reflects the weighted average sales price."}],"balance_after":91309,"source":{"system":"sec-edgar","filing":"0001846487-26-000014","document":"wk-form4_1773437295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000014/wk-form4_1773437295.xml","form_type":"4"}},{"id":851882,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:44.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":3602,"price":74.18,"value":267196.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $73.27 to $74.81. The price reported above reflects the weighted average sales price."}],"balance_after":94471,"source":{"system":"sec-edgar","filing":"0001846487-26-000012","document":"wk-form4_1773173381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000012/wk-form4_1773173381.xml","form_type":"4"}},{"id":851881,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:44.000Z","date":"2026-03-07","kind":"tax_withholding","planned":true,"acquired":false,"shares":3314,"price":74.04,"value":245368.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported."}],"balance_after":98073,"source":{"system":"sec-edgar","filing":"0001846487-26-000012","document":"wk-form4_1773173381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000012/wk-form4_1773173381.xml","form_type":"4"}},{"id":851880,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:44.000Z","date":"2026-03-06","kind":"sale","planned":true,"acquired":false,"shares":2121,"price":74.22,"value":157420.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $73.14 to $75.00. The price reported above reflects the weighted average sales price."}],"balance_after":101387,"source":{"system":"sec-edgar","filing":"0001846487-26-000012","document":"wk-form4_1773173381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000012/wk-form4_1773173381.xml","form_type":"4"}},{"id":863067,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-04T23:46:47.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":417,"price":74,"value":30858.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."}],"balance_after":103508,"source":{"system":"sec-edgar","filing":"0001846487-26-000010","document":"wk-form4_1772668004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000010/wk-form4_1772668004.xml","form_type":"4"}},{"id":875178,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:15.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":73.9,"value":164131.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":103925,"source":{"system":"sec-edgar","filing":"0001846487-26-000008","document":"wk-form4_1772492353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000008/wk-form4_1772492353.xml","form_type":"4"}},{"id":875177,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:15.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":21306,"price":77.15,"value":1643757.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":106146,"source":{"system":"sec-edgar","filing":"0001846487-26-000008","document":"wk-form4_1772492353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000008/wk-form4_1772492353.xml","form_type":"4"}},{"id":888917,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:50.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":5323,"price":78.02,"value":415300.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $77.20 to $78.58. The price reported above reflects the weighted average sales price."}],"balance_after":84840,"source":{"system":"sec-edgar","filing":"0001846487-26-000006","document":"wk-form4_1771885908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000006/wk-form4_1771885908.xml","form_type":"4"}},{"id":902019,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:03.000Z","date":"2026-02-14","kind":"tax_withholding","planned":true,"acquired":false,"shares":2403,"price":77.36,"value":185896.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":90163,"source":{"system":"sec-edgar","filing":"0001846487-26-000004","document":"wk-form4_1771362479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000004/wk-form4_1771362479.xml","form_type":"4"}},{"id":902018,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:03.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":7032,"price":76.55,"value":538299.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at prices ranging from $75.43 to $76.92. The price reported above reflects the weighted average sales price."}],"balance_after":92566,"source":{"system":"sec-edgar","filing":"0001846487-26-000004","document":"wk-form4_1771362479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000004/wk-form4_1771362479.xml","form_type":"4"}},{"id":902017,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:03.000Z","date":"2026-02-12","kind":"tax_withholding","planned":true,"acquired":false,"shares":3173,"price":76.7,"value":243369.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,202 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":99598,"source":{"system":"sec-edgar","filing":"0001846487-26-000004","document":"wk-form4_1771362479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000004/wk-form4_1771362479.xml","form_type":"4"}},{"id":905860,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-13T21:08:56.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4546,"price":76.25,"value":346632.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":102771,"source":{"system":"sec-edgar","filing":"0001846487-26-000002","document":"wk-form4_1771016933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000002/wk-form4_1771016933.xml","form_type":"4"}},{"id":1148025,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-05-16T00:10:46.000Z","date":"2025-05-14","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":60.45,"value":241800.0,"ownership":{"direct":true},"balance_after":107317,"source":{"system":"sec-edgar","filing":"0001846487-25-000008","document":"wk-form4_1747354237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000008/wk-form4_1747354237.xml","form_type":"4"}},{"id":1206424,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-03-14T21:22:35.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2874,"price":60.62,"value":174221.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported."}],"balance_after":111317,"source":{"system":"sec-edgar","filing":"0001846487-25-000006","document":"wk-form4_1741987349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000006/wk-form4_1741987349.xml","form_type":"4"}},{"id":1231387,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-03-04T22:12:21.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1275,"price":61.89,"value":78909.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":114191,"source":{"system":"sec-edgar","filing":"0001846487-25-000004","document":"wk-form4_1741126332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000004/wk-form4_1741126332.xml","form_type":"4"}},{"id":1264826,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-02-19T01:17:30.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1184,"price":58.92,"value":69761.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported."}],"balance_after":115466,"source":{"system":"sec-edgar","filing":"0001846487-25-000002","document":"wk-form4_1739927844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000002/wk-form4_1739927844.xml","form_type":"4"}},{"id":1264825,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-02-19T01:17:30.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1473,"price":58.92,"value":86789.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported."}],"balance_after":116650,"source":{"system":"sec-edgar","filing":"0001846487-25-000002","document":"wk-form4_1739927844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000002/wk-form4_1739927844.xml","form_type":"4"}},{"id":1264824,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-02-19T01:17:30.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":16538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":118123,"source":{"system":"sec-edgar","filing":"0001846487-25-000002","document":"wk-form4_1739927844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000002/wk-form4_1739927844.xml","form_type":"4"}},{"id":1264823,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2025-02-19T01:17:30.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":24808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025."}],"balance_after":101585,"source":{"system":"sec-edgar","filing":"0001846487-25-000002","document":"wk-form4_1739927844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648725000002/wk-form4_1739927844.xml","form_type":"4"}},{"id":1362367,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-11-18T21:03:26.000Z","date":"2024-11-15","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":57.7,"value":375050.0,"ownership":{"direct":true},"balance_after":76777,"source":{"system":"sec-edgar","filing":"0001846487-24-000014","document":"wk-form4_1731963799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000014/wk-form4_1731963799.xml","form_type":"4"}},{"id":1506013,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-05-22T22:14:28.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":61.61,"value":123220.0,"ownership":{"direct":true},"balance_after":83277,"source":{"system":"sec-edgar","filing":"0001846487-24-000012","document":"wk-form4_1716416059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000012/wk-form4_1716416059.xml","form_type":"4"}},{"id":1589865,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-03-08T02:16:48.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2110,"price":66.71,"value":140758.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported."}],"balance_after":85277,"source":{"system":"sec-edgar","filing":"0001846487-24-000010","document":"wk-form4_1709864200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000010/wk-form4_1709864200.xml","form_type":"4"}},{"id":1592596,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-03-06T21:24:34.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":66,"value":330000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $65.77 to $66.49. The price reported above reflects the weighted average sales price."}],"balance_after":87387,"source":{"system":"sec-edgar","filing":"0001846487-24-000008","document":"wk-form4_1709760262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000008/wk-form4_1709760262.xml","form_type":"4"}},{"id":1608053,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-03-01T22:12:45.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1275,"price":67.67,"value":86279.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":92387,"source":{"system":"sec-edgar","filing":"0001846487-24-000006","document":"wk-form4_1709331156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000006/wk-form4_1709331156.xml","form_type":"4"}},{"id":1635174,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-02-20T22:02:17.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1261,"price":57.55,"value":72570.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,034 shares of restricted stock, the grant of which was previously reported."}],"balance_after":93662,"source":{"system":"sec-edgar","filing":"0001846487-24-000004","document":"wk-form4_1708466458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000004/wk-form4_1708466458.xml","form_type":"4"}},{"id":1639213,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-02-16T21:50:42.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":12526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":94923,"source":{"system":"sec-edgar","filing":"0001846487-24-000002","document":"wk-form4_1708120221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000002/wk-form4_1708120221.xml","form_type":"4"}},{"id":1639212,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2024-02-16T21:50:42.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":18790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024."}],"balance_after":82397,"source":{"system":"sec-edgar","filing":"0001846487-24-000002","document":"wk-form4_1708120221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648724000002/wk-form4_1708120221.xml","form_type":"4"}},{"id":1744577,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2023-11-13T21:02:30.000Z","date":"2023-11-10","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":52.47,"value":157410.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.41 to $52.58, inclusive."}],"balance_after":63607,"source":{"system":"sec-edgar","filing":"0001846487-23-000003","document":"wk-form4_1699909333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648723000003/wk-form4_1699909333.xml","form_type":"4"}},{"id":1929765,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2023-04-05T00:07:28.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":11578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":66607,"source":{"system":"sec-edgar","filing":"0001104659-23-041738","document":"tm2311710-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041738/tm2311710-7_4seq1.xml","form_type":"4"}},{"id":1929764,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2023-04-05T00:07:28.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":17369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023."}],"balance_after":55029,"source":{"system":"sec-edgar","filing":"0001104659-23-041738","document":"tm2311710-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041738/tm2311710-7_4seq1.xml","form_type":"4"}},{"id":1961572,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2023-03-09T23:48:05.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":476,"price":44.23,"value":21053.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported."}],"balance_after":37660,"source":{"system":"sec-edgar","filing":"0001104659-23-030710","document":"tm239061-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923030710/tm239061-5_4seq1.xml","form_type":"4"}},{"id":1961571,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2023-03-09T23:48:05.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":1426,"price":44.23,"value":63071.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported."}],"balance_after":38136,"source":{"system":"sec-edgar","filing":"0001104659-23-030710","document":"tm239061-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923030710/tm239061-5_4seq1.xml","form_type":"4"}},{"id":2008793,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2023-02-17T21:32:04.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":1292,"price":45.04,"value":58191.68,"ownership":{"direct":true},"balance_after":39562,"source":{"system":"sec-edgar","filing":"0001104659-23-023305","document":"tm237192-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923023305/tm237192-2_4seq1.xml","form_type":"4"}},{"id":2288149,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2022-04-29T22:37:15.000Z","date":"2022-04-27","kind":"grant","acquired":true,"shares":6476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022."}],"balance_after":40854,"source":{"system":"sec-edgar","filing":"0001415889-22-004411","document":"form4-04292022_030430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922004411/form4-04292022_030430.xml","form_type":"4"}},{"id":2316970,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2022-03-29T00:51:30.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":19428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022."}],"balance_after":34378,"source":{"system":"sec-edgar","filing":"0001415889-22-003396","document":"form4-03282022_050322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003396/form4-03282022_050322.xml","form_type":"4"}},{"id":2389443,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2022-02-18T00:24:41.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":1184,"price":40.25,"value":47656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,033 shares of restricted stock, the grant of which was previously reported."}],"balance_after":14950,"source":{"system":"sec-edgar","filing":"0001415889-22-001535","document":"form4-02172022_040230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922001535/form4-02172022_040230.xml","form_type":"4"}},{"id":2855838,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T02:57:38.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":33758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable as to 25% of the total shares on each of February 15, 2022, February 15, 2023, February 15, 2024 and February 15, 2025."}],"balance_after":33758,"derivative":{"exercise_price":31.49,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":33758},"source":{"system":"sec-edgar","filing":"0001415889-21-000745","document":"form4-02172021_060228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921000745/form4-02172021_060228.xml","form_type":"4"}},{"id":2855837,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2021-02-18T02:57:38.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":16134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award that will vest as to 25% of the total shares on each of February 15, 2022, February 15, 2023, February 15, 2024 and February 15, 2025."}],"balance_after":16134,"source":{"system":"sec-edgar","filing":"0001415889-21-000745","document":"form4-02172021_060228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921000745/form4-02172021_060228.xml","form_type":"4"}}]}